Advertisement
Screener

Beam Therapeutics Inc. (BEAM) ROA

Beam Therapeutics Inc. (BEAM) ROA

  • 2026-06-30: ROA -6.16%.
  • 2026-03-31: ROA -4.38%.
  • 2025-12-31: ROA -5.33%.
  • 2025-09-30: ROA -31.54%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-6.16%
2026-03-31-4.38%
2025-12-31-5.33%
2025-09-30-31.54%
2025-06-30-28.57%
2025-03-31-26.34%
2024-12-31-34.13%
2024-09-30-12.26%
2024-06-30-11.34%
2024-03-31-9.91%
2023-12-31-9.08%
2023-09-30-24.31%
2023-06-30-24.16%
2023-03-31-23.74%
2022-12-31-21.55%
2022-09-30-23.36%
2022-06-30-16.50%
2022-03-31-16.40%
2021-12-31-25.14%
2021-09-30-34.71%
2021-06-30-45.65%
2021-03-31-52.75%
2020-12-31-43.08%
2020-09-30-45.63%
2020-06-30-37.18%
2020-03-31-29.50%
2019-12-31-50.18%

Annual ROA

DateROA
2025-12-31-5.40%
2024-12-31-34.13%
2023-12-31-9.08%
2022-12-31-21.55%
2021-12-31-25.14%
2020-12-31-43.08%
2019-12-31-50.18%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
NOVAVAX INC (NVAX)United States$1.748B-6.26